AZ funded Non-clinical PhD Studentship (Fixed Term) in selective nanoparticle targeting of senescent alveolar epithelium using an alveolar organoid model

AZ funded Non-clinical PhD Studentship (Fixed Term) in selective nanoparticle targeting of senescent alveolar epithelium using an alveolar organoid model Applications are invited for 4-year PhD studentship based in Cambridge Institute of Medical Research (CIMR), University of Cambridge and the new AstraZeneca Discovery Centre at Cambridge. The student will be working on a collaborative project jointly supervised by Dr Jennifer Dickens in CIMR and Dr James Garnett and Dr Catherine Overed-Sayer at AstraZeneca and will work have opportunity to work across the two sites. Project Overview Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal interstitial lung disease (ILD) in which alveolar type 2 (AT2) cell epithelial dysfunction plays a key initiating role. Epithelial senescence is increasingly recognised as playing a role in triggering and perpetuating disease.